ID Biomedical (IDB.TO) Buy, Sell or Hold

ID Biomedical (IDB.TO)

0.00

-0.00 (0.00%)

0 watching

HOLD

GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares.

BUY

Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside.

DON'T BUY

Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive.

BUY

The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products.

BUY ON WEAKNESS

Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while.

BUY ON WEAKNESS

Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level.

BUY

Good product. In final phases of testing.

WEAK BUY

Very volatile. Well managed and has a lot of cash.

BUY

Still has substantial upside. Into some interesting products.

PAST TOP PICK

(Was a top pick on Dec 21 up 50%) Can still go higher.

TOP PICK

Well capitalized. Strong management.

TOP PICK

Strong cash position. Good mngmnt. Good outlook.

TOP PICK

Well capitalized. Good product line.

TOP PICK

New acquisition is a good fit. Strong cash positions.

Showing 1 to 15 of 19 entries

ID Biomedical (IDB.TO) Frequently Asked Questions

What is ID Biomedical stock symbol?

ID Biomedical is a OTC stock, trading under the symbol IDB.TO (previously IDB-T on Stockchase) on the undefined (undefined). It is usually referred to as or IDB.TO

Is ID Biomedical a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on IDB.TO (previously IDB-T on Stockchase) on Stockchase. Read the latest expert commentary for ID Biomedical.

Is ID Biomedical a good investment or a top pick?

ID Biomedical was recommended as a Top Pick by Robert Floyd on 2001-03-28. Read the latest stock experts ratings for ID Biomedical.

Why is ID Biomedical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for ID Biomedical.

Is ID Biomedical worth watching?

ID Biomedical is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

ID Biomedical (IDB.TO)